Genomic Insights into Fusarium verticillioides Diversity: The Genome of Two Clinical Isolates and Their Demethylase Inhibitor Fungicides Susceptibility

<i>Fusarium verticillioides</i> is an important plant pathogen in maize and other cereals that is seldom detected as the cause of human fusariosis. Here, we provide the analysis of the available diversity of <i>F. verticillioides</i> sequenced worldwide and report the first two genome assemblies and annotations (including mitochondrial DNA) of <i>Fusarium verticillioides</i> from clinical settings. <i>Fusarium verticillioides</i> 05-0160 (IUM05-0160) and <i>Fusarium verticillioides</i> 09-1037 (IUM09-1037) strains were obtained from the bone marrow and blood of two immunocompromised patients, respectively. The phylogenomic analysis confirmed the species identity of our two strains. Comparative genomic analyses among the reannotated <i>F. verticillioides</i> genomes (<i>n</i> = 46) did not lead to the identification of unique genes specific to the clinical samples. Two subgroups in the <i>F. verticillioides</i> clade were also identified and confirmed by a mitochondrial diversity study. Clinical strains (<i>n</i> = 4) were positioned in the multigene phylogenetic tree without any correlation between the host and the tree branches, grouping with plant-derived strains. To investigate the existence of a potential fitness advantage of our two clinical strains, we compared demethylase inhibitor fungicides susceptibility against the reference <i>Fusarium verticillioides</i> 7600, showing, on average, lower susceptibility to agricultural and medical-used antifungals. A significant reduction in susceptibility was observed for itraconazole and tetraconazole, which might be explained by structural changes in CYP51A and CYP51C sequences. By providing the first two annotated genomes of <i>F. verticillioides</i> from clinical settings comprehensive of their mitogenomes, this study can serve as a base for exploring the fitness and adaptation capacities of <i>Fusarium verticillioides</i> infecting different kingdoms.

Authors

Institutions

Publication Details

Journal
Pathogens
Published
2024-12-03
DOI
https://doi.org/10.3390/pathogens13121062
Citations
2
Primary Topic
Plant Pathogens and Fungal Diseases
Type
article
Field-Weighted Citation Impact
0.65
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Genomic Insights into Fusarium verticillioides Diversity: The Genome of Two Clinical Isolates and Their Demethylase Inhibitor Fungicides Susceptibility

Daniela Bulgari, Maria Carmela Esposto, Anna Prigitano, Luca Degradi et al.
2 citations
Pathogens
Plant Pathogens and Fungal Diseases
0.65
article

Genomic Insights into Fusarium verticillioides Diversity: The Genome of Two Clinical Isolates and Their Demethylase Inhibitor Fungicides Susceptibility

Daniela Bulgari, Maria Carmela Esposto, Anna Prigitano, Luca Degradi, Valeria Tava, Andrea Kunova, P. Cortesi, M. Saracchi, Matias Pasquali
article en
2 citations

Abstract

<i>Fusarium verticillioides</i> is an important plant pathogen in maize and other cereals that is seldom detected as the cause of human fusariosis. Here, we provide the analysis of the available diversity of <i>F. verticillioides</i> sequenced worldwide and report the first two genome assemblies and annotations (including mitochondrial DNA) of <i>Fusarium verticillioides</i> from clinical settings. <i>Fusarium verticillioides</i> 05-0160 (IUM05-0160) and <i>Fusarium verticillioides</i> 09-1037 (IUM09-1037) strains were obtained from the bone marrow and blood of two immunocompromised patients, respectively. The phylogenomic analysis confirmed the species identity of our two strains. Comparative genomic analyses among the reannotated <i>F. verticillioides</i> genomes (<i>n</i> = 46) did not lead to the identification of unique genes specific to the clinical samples. Two subgroups in the <i>F. verticillioides</i> clade were also identified and confirmed by a mitochondrial diversity study. Clinical strains (<i>n</i> = 4) were positioned in the multigene phylogenetic tree without any correlation between the host and the tree branches, grouping with plant-derived strains. To investigate the existence of a potential fitness advantage of our two clinical strains, we compared demethylase inhibitor fungicides susceptibility against the reference <i>Fusarium verticillioides</i> 7600, showing, on average, lower susceptibility to agricultural and medical-used antifungals. A significant reduction in susceptibility was observed for itraconazole and tetraconazole, which might be explained by structural changes in CYP51A and CYP51C sequences. By providing the first two annotated genomes of <i>F. verticillioides</i> from clinical settings comprehensive of their mitogenomes, this study can serve as a base for exploring the fitness and adaptation capacities of <i>Fusarium verticillioides</i> infecting different kingdoms.

PathogensVol. 13(12)
University of Milan (IT), KU Leuven (BE)
Zero hunger
Openalex Percentile: Top 31%
Plant Pathogens and Fungal Diseases
0.65
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.